PDEs as drug targets

Phosphodiesterases make good drug targets because they bind small ligands and share similar catalytic mechanisms, while displaying unique architectures around their active sites. This allows for the development of selective inhibitors.

Read more

PDE4NPD and the EU

The PDE4NPD Project is one of four neglected parasitic disease (NPD) projects funded under the auspices of the European Commission’s FP7 HEALTH programme.

Read more

Latest news

PDE4NPD researcher wins BSP poster prize

31 May 2017

Seven Poster Prizes were awarded at this year's BSP meeting in Dundee.  Titilola Kalejaiye won the best student poster prize of £100 for her poster "Evaluation of phosphodiesterase as potential drug targets in Trypanosoma cruzi."

Read more